Caxton Associates (UK)’s Dyne Therapeutics DYN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$158K Buy
16,599
+1,627
+11% +$15.5K ﹤0.01% 646
2025
Q1
$157K Buy
+14,972
New +$157K 0.01% 722